Takeda Pharmaceutical Co Ltd
TSE:4502
Takeda Pharmaceutical Co Ltd
TSE:4502
Price:
4 213
JPY
0.29%
Market Closed
Market Cap:
6.7T
JPY
Add
Note
Why Create Notes?
Capture your thoughts
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Estee Lauder Companies Inc
NYSE:EL
|
Consumer products
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Church & Dwight Co Inc
NYSE:CHD
|
Consumer products
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
American Express Co
NYSE:AXP
|
Financial Services
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Target Corp
NYSE:TGT
|
Retail
|
| US |
|
Walt Disney Co
NYSE:DIS
|
Media
|
| US |
|
Mueller Industries Inc
NYSE:MLI
|
Machinery
|
| US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
Technology
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Peter Lynch
Track and Analyze Performance
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Continuous Learning and Adaptation
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
Boost Decision Confidence
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Delete Note
Do you really want to delete this note?
This action cannot be undone.
Alert
Takeda Pharmaceutical Co Ltd
4213
+12 (+0.29%)
| 52 Week Range |
3 903
4 482
|
| Price Target |
|
We'll email you a reminder when the closing price reaches JPY.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Estee Lauder Companies Inc
NYSE:EL
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Church & Dwight Co Inc
NYSE:CHD
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
American Express Co
NYSE:AXP
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Target Corp
NYSE:TGT
|
US |
|
|
Walt Disney Co
NYSE:DIS
|
US |
|
|
Mueller Industries Inc
NYSE:MLI
|
US |
|
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Delete Alert
This alert will be permanently deleted.
Ask me anything about
Takeda Pharmaceutical Co Ltd
Income Statement
Earnings Waterfall
Takeda Pharmaceutical Co Ltd
Takeda Pharmaceutical Co Ltd
|
Revenue
|
4.4T
JPY
|
|
Cost of Revenue
|
-1.5T
JPY
|
|
Gross Profit
|
2.9T
JPY
|
|
Operating Expenses
|
-2.5T
JPY
|
|
Operating Income
|
403B
JPY
|
|
Other Expenses
|
-253.1B
JPY
|
|
Net Income
|
149.9B
JPY
|
Income Statement
Takeda Pharmaceutical Co Ltd
Takeda Pharmaceutical Co Ltd
Currency: JPY
| Jun-2014 | Sep-2014 | Dec-2014 | Mar-2015 | Jun-2015 | Sep-2015 | Dec-2015 | Mar-2016 | Jun-2016 | Sep-2016 | Dec-2016 | Mar-2017 | Jun-2017 | Sep-2017 | Dec-2017 | Mar-2018 | Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||||||||||||||||||||||||||||||||||||
| Revenue |
1 692 521
N/A
|
1 714 986
+1%
|
1 744 798
+2%
|
1 777 824
+2%
|
1 812 971
+2%
|
1 830 521
+1%
|
1 831 096
+0%
|
1 807 378
-1%
|
1 795 088
-1%
|
1 754 129
-2%
|
1 729 966
-1%
|
1 732 051
+0%
|
1 746 285
+1%
|
1 762 667
+1%
|
1 785 773
+1%
|
1 770 531
-1%
|
1 772 125
+0%
|
1 769 725
0%
|
1 780 976
+1%
|
2 097 224
+18%
|
2 496 511
+19%
|
2 876 782
+15%
|
3 236 697
+13%
|
3 291 188
+2%
|
3 243 917
-1%
|
3 221 804
-1%
|
3 199 240
-1%
|
3 197 812
0%
|
3 345 565
+5%
|
3 401 449
+2%
|
3 465 990
+2%
|
3 569 006
+3%
|
3 591 867
+1%
|
3 749 355
+4%
|
3 944 612
+5%
|
4 027 478
+2%
|
4 113 632
+2%
|
4 154 414
+1%
|
4 169 049
+0%
|
4 263 762
+2%
|
4 413 134
+4%
|
|
| Gross Profit | ||||||||||||||||||||||||||||||||||||||||||
| Cost of Revenue |
(490 387)
|
(499 198)
|
(507 081)
|
(520 990)
|
(524 072)
|
(531 417)
|
(537 023)
|
(535 405)
|
(549 679)
|
(554 848)
|
(557 312)
|
(558 755)
|
(544 227)
|
(524 638)
|
(519 435)
|
(495 921)
|
(495 642)
|
(484 520)
|
(480 747)
|
(651 729)
|
(822 936)
|
(982 396)
|
(1 123 457)
|
(1 089 764)
|
(1 036 045)
|
(1 015 476)
|
(989 043)
|
(994 308)
|
(997 494)
|
(1 023 649)
|
(1 051 911)
|
(1 106 846)
|
(1 158 463)
|
(1 188 111)
|
(1 242 680)
|
(1 244 072)
|
(1 272 304)
|
(1 310 441)
|
(1 353 949)
|
(1 426 678)
|
(1 492 518)
|
|
| Gross Profit |
1 202 134
N/A
|
1 215 788
+1%
|
1 237 717
+2%
|
1 256 834
+2%
|
1 288 899
+3%
|
1 299 104
+1%
|
1 294 073
0%
|
1 271 973
-2%
|
1 245 409
-2%
|
1 199 281
-4%
|
1 172 654
-2%
|
1 173 296
+0%
|
1 202 058
+2%
|
1 238 029
+3%
|
1 266 338
+2%
|
1 274 610
+1%
|
1 276 483
+0%
|
1 285 205
+1%
|
1 300 229
+1%
|
1 445 495
+11%
|
1 673 575
+16%
|
1 894 386
+13%
|
2 113 240
+12%
|
2 201 424
+4%
|
2 207 872
+0%
|
2 206 328
0%
|
2 210 197
+0%
|
2 203 504
0%
|
2 348 071
+7%
|
2 377 800
+1%
|
2 414 079
+2%
|
2 462 160
+2%
|
2 433 404
-1%
|
2 561 244
+5%
|
2 701 932
+5%
|
2 783 406
+3%
|
2 841 328
+2%
|
2 843 973
+0%
|
2 815 100
-1%
|
2 837 084
+1%
|
2 920 616
+3%
|
|
| Operating Income | ||||||||||||||||||||||||||||||||||||||||||
| Operating Expenses |
(1 074 278)
|
(1 097 751)
|
(1 098 090)
|
(1 168 145)
|
(1 432 283)
|
(1 434 604)
|
(1 454 900)
|
(1 124 810)
|
(1 011 208)
|
(1 016 827)
|
(991 876)
|
(982 043)
|
(1 004 149)
|
(1 009 889)
|
(1 005 614)
|
(1 071 771)
|
(1 130 799)
|
(1 105 809)
|
(1 096 307)
|
(1 262 007)
|
(1 456 131)
|
(1 656 921)
|
(1 997 431)
|
(1 914 922)
|
(1 932 203)
|
(1 933 742)
|
(1 827 169)
|
(1 867 782)
|
(1 648 811)
|
(1 643 158)
|
(1 700 139)
|
(1 916 672)
|
(2 070 597)
|
(2 191 426)
|
(2 253 648)
|
(2 232 511)
|
(2 300 426)
|
(2 347 301)
|
(2 350 215)
|
(2 536 889)
|
(2 517 567)
|
|
| Selling, General & Administrative |
(563 179)
|
(578 799)
|
(595 369)
|
(614 854)
|
(637 726)
|
(642 957)
|
(650 103)
|
(650 773)
|
(634 034)
|
(628 218)
|
(614 620)
|
(619 061)
|
(619 972)
|
(625 384)
|
(636 026)
|
(628 106)
|
(627 266)
|
(624 625)
|
(619 443)
|
(717 599)
|
(811 784)
|
(886 285)
|
(981 601)
|
(964 737)
|
(927 898)
|
(920 899)
|
(894 333)
|
(875 663)
|
(893 132)
|
(888 886)
|
(897 320)
|
(886 361)
|
(897 998)
|
(934 721)
|
(965 942)
|
(997 309)
|
(1 013 942)
|
(1 018 160)
|
(1 023 381)
|
(1 053 819)
|
(1 075 736)
|
|
| Research & Development |
(337 474)
|
(342 196)
|
(351 800)
|
(382 096)
|
(387 932)
|
(386 950)
|
(386 767)
|
0
|
(341 486)
|
(336 520)
|
(315 828)
|
(312 303)
|
(311 441)
|
(315 433)
|
(325 164)
|
(325 441)
|
(321 720)
|
(321 778)
|
(317 675)
|
(368 298)
|
(413 198)
|
(447 229)
|
(492 477)
|
(492 381)
|
(482 336)
|
(486 996)
|
0
|
(455 833)
|
(353 926)
|
(367 369)
|
(495 747)
|
(526 087)
|
(547 213)
|
(569 758)
|
(616 009)
|
(633 325)
|
(652 459)
|
(682 260)
|
(695 012)
|
(729 924)
|
(735 646)
|
|
| Depreciation & Amortization |
(144 808)
|
(147 789)
|
(181 184)
|
(176 402)
|
(179 023)
|
(176 146)
|
(142 990)
|
(125 140)
|
(120 276)
|
(137 863)
|
(134 238)
|
(156 717)
|
(160 692)
|
(137 915)
|
(140 899)
|
(122 131)
|
(113 662)
|
(113 534)
|
(115 176)
|
(178 617)
|
(276 348)
|
(355 552)
|
(428 375)
|
(455 420)
|
(437 918)
|
(438 294)
|
(433 842)
|
(421 864)
|
(420 438)
|
(419 312)
|
(437 926)
|
(472 915)
|
(501 368)
|
(541 013)
|
(558 502)
|
(542 443)
|
(534 389)
|
(522 715)
|
(520 920)
|
(652 117)
|
(548 218)
|
|
| Other Operating Expenses |
(28 817)
|
(28 967)
|
30 263
|
5 207
|
(227 602)
|
(228 551)
|
(275 040)
|
(348 897)
|
84 588
|
85 774
|
72 810
|
106 038
|
87 956
|
68 843
|
96 475
|
3 907
|
(68 151)
|
(45 872)
|
(44 013)
|
2 507
|
45 199
|
32 145
|
(94 978)
|
(2 384)
|
(84 051)
|
(87 553)
|
(498 994)
|
(114 422)
|
18 685
|
32 409
|
130 854
|
(31 309)
|
(124 018)
|
(145 934)
|
(113 195)
|
(59 434)
|
(99 636)
|
(124 166)
|
(110 902)
|
(101 029)
|
(157 967)
|
|
| Operating Income |
127 856
N/A
|
118 037
-8%
|
139 627
+18%
|
88 689
-36%
|
(143 384)
N/A
|
(135 500)
+5%
|
(160 827)
-19%
|
147 163
N/A
|
234 201
+59%
|
182 454
-22%
|
180 778
-1%
|
191 253
+6%
|
197 909
+3%
|
228 140
+15%
|
260 724
+14%
|
202 839
-22%
|
145 684
-28%
|
179 396
+23%
|
203 922
+14%
|
183 488
-10%
|
217 444
+19%
|
237 465
+9%
|
115 809
-51%
|
286 502
+147%
|
275 669
-4%
|
272 586
-1%
|
383 028
+41%
|
335 722
-12%
|
699 260
+108%
|
734 642
+5%
|
713 940
-3%
|
545 488
-24%
|
362 807
-33%
|
369 818
+2%
|
448 284
+21%
|
550 895
+23%
|
540 902
-2%
|
496 672
-8%
|
464 885
-6%
|
300 195
-35%
|
403 049
+34%
|
|
| Pre-Tax Income | ||||||||||||||||||||||||||||||||||||||||||
| Interest Income Expense |
17 267
|
5 721
|
(14 206)
|
2 760
|
(13 323)
|
(21 035)
|
(17 571)
|
2 455
|
(12 706)
|
(8 935)
|
(6 025)
|
(3 401)
|
(5 999)
|
(6 826)
|
(38 308)
|
42 549
|
(32 858)
|
(34 399)
|
(66 229)
|
(97 077)
|
(140 118)
|
(176 764)
|
(140 568)
|
(158 213)
|
(163 104)
|
(173 322)
|
(177 998)
|
(234 717)
|
(131 614)
|
(114 561)
|
(125 507)
|
(142 628)
|
(127 741)
|
(131 651)
|
(127 197)
|
(158 203)
|
(153 912)
|
(160 660)
|
(164 477)
|
(196 482)
|
(157 471)
|
|
| Non-Reccuring Items |
17 882
|
28 003
|
21 983
|
(236 887)
|
0
|
0
|
0
|
(29 079)
|
0
|
0
|
0
|
(44 507)
|
0
|
0
|
0
|
(28 183)
|
0
|
0
|
0
|
41 201
|
(33 462)
|
(62 703)
|
0
|
(189 043)
|
(53 143)
|
(65 623)
|
(86 435)
|
265 230
|
(108 724)
|
(94 982)
|
(100 937)
|
(100 290)
|
0
|
0
|
(47 960)
|
(17 602)
|
(32 341)
|
(141 891)
|
(152 180)
|
(50 923)
|
(191 217)
|
|
| Total Other Income |
(1)
|
(1)
|
0
|
0
|
2
|
2
|
1
|
0
|
(1)
|
(1)
|
(1)
|
1
|
2
|
2
|
2
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
|
| Pre-Tax Income |
163 004
N/A
|
151 760
-7%
|
147 404
-3%
|
(145 437)
N/A
|
(156 705)
-8%
|
(156 533)
+0%
|
(178 397)
-14%
|
120 539
N/A
|
221 494
+84%
|
173 518
-22%
|
174 752
+1%
|
143 346
-18%
|
191 912
+34%
|
221 316
+15%
|
222 418
+0%
|
217 205
-2%
|
112 826
-48%
|
144 997
+29%
|
137 693
-5%
|
127 612
-7%
|
43 864
-66%
|
(2 002)
N/A
|
(24 759)
-1 137%
|
(60 754)
-145%
|
59 422
N/A
|
33 641
-43%
|
118 595
+253%
|
366 235
+209%
|
458 922
+25%
|
525 099
+14%
|
487 496
-7%
|
302 571
-38%
|
235 066
-22%
|
238 168
+1%
|
273 128
+15%
|
375 090
+37%
|
354 650
-5%
|
194 121
-45%
|
148 228
-24%
|
52 791
-64%
|
54 362
+3%
|
|
| Net Income | ||||||||||||||||||||||||||||||||||||||||||
| Tax Provision |
(55 728)
|
(59 584)
|
(92 309)
|
2 403
|
4 790
|
6 334
|
69 383
|
(37 059)
|
(63 100)
|
(20 418)
|
(39 600)
|
(27 833)
|
(31 753)
|
(58 741)
|
(34 252)
|
(30 497)
|
6 973
|
(4 470)
|
(27 321)
|
7 468
|
20 169
|
85 427
|
38 214
|
105 044
|
60 354
|
22 404
|
61 994
|
9 936
|
(27 544)
|
(51 796)
|
(48 811)
|
(72 405)
|
(37 605)
|
(24 970)
|
1 399
|
(58 052)
|
(53 227)
|
(2 401)
|
30 099
|
91 406
|
95 729
|
|
| Income from Continuing Operations |
107 276
|
92 176
|
55 095
|
(143 034)
|
(151 915)
|
(150 199)
|
(109 014)
|
83 480
|
158 394
|
153 100
|
135 152
|
115 513
|
160 159
|
162 575
|
188 166
|
186 708
|
119 799
|
140 527
|
110 372
|
135 080
|
64 033
|
83 425
|
13 455
|
44 290
|
119 776
|
56 045
|
180 589
|
376 171
|
431 378
|
473 303
|
438 685
|
230 166
|
197 461
|
213 198
|
274 527
|
317 038
|
301 423
|
191 720
|
178 327
|
144 197
|
150 091
|
|
| Income to Minority Interest |
(3 162)
|
(2 830)
|
(1 971)
|
(2 741)
|
(2 676)
|
(2 626)
|
(2 860)
|
(3 313)
|
(3 283)
|
(3 019)
|
(2 956)
|
(573)
|
43
|
881
|
2 006
|
178
|
540
|
211
|
42
|
112
|
(74)
|
(163)
|
(180)
|
(49)
|
(33)
|
6
|
42
|
(166)
|
(201)
|
(199)
|
(171)
|
(107)
|
(72)
|
(31)
|
(2)
|
(21)
|
(25)
|
(94)
|
(109)
|
(130)
|
(171)
|
|
| Net Income (Common) |
104 113
N/A
|
89 346
-14%
|
53 122
-41%
|
(145 775)
N/A
|
(154 591)
-6%
|
(152 826)
+1%
|
(111 874)
+27%
|
80 166
N/A
|
155 109
+93%
|
150 080
-3%
|
132 194
-12%
|
114 940
-13%
|
160 202
+39%
|
163 457
+2%
|
190 172
+16%
|
186 886
-2%
|
120 339
-36%
|
140 737
+17%
|
110 414
-22%
|
135 192
+22%
|
63 959
-53%
|
83 262
+30%
|
13 275
-84%
|
44 241
+233%
|
119 743
+171%
|
56 051
-53%
|
180 631
+222%
|
376 005
+108%
|
431 178
+15%
|
473 105
+10%
|
438 516
-7%
|
230 059
-48%
|
197 390
-14%
|
213 168
+8%
|
274 525
+29%
|
317 017
+15%
|
301 398
-5%
|
191 626
-36%
|
178 217
-7%
|
144 067
-19%
|
149 918
+4%
|
|
| EPS (Diluted) |
131.95
N/A
|
113.38
-14%
|
67.32
-41%
|
-185.37
N/A
|
-195.68
-6%
|
-193.45
+1%
|
-141.61
+27%
|
101.71
N/A
|
197.59
+94%
|
191.42
-3%
|
168.4
-12%
|
146.25
-13%
|
204.07
+40%
|
207.96
+2%
|
241.94
+16%
|
237.56
-2%
|
153.1
-36%
|
178.6
+17%
|
140.03
-22%
|
139.82
0%
|
41
-71%
|
53.29
+30%
|
8.52
-84%
|
28.25
+232%
|
76.45
+171%
|
35.63
-53%
|
114.63
+222%
|
238.96
+108%
|
273.86
+15%
|
299.35
+9%
|
278.42
-7%
|
145.87
-48%
|
127.7
-12%
|
136.31
+7%
|
174.81
+28%
|
201.94
+16%
|
192.58
-5%
|
122.42
-36%
|
112.43
-8%
|
92.09
-18%
|
94.34
+2%
|
|
Switch to:
Switch to:
See Also
Discover More
You don't have any saved screeners yet
